Production of 99Mo at IFMIF-DONES reusing the flux of neutrons
The accelerator-based neutron facility IFMIF-DONES is in the final design phase. At present, there is an important effort to optimize other secondary uses compatible with the main goal which is the validation of materials to be used in fusion reactors. One is the production of radioisotopes for nucl...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-03-01
|
| Series: | Nuclear Materials and Energy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352179123002144 |
| _version_ | 1797262948622663680 |
|---|---|
| author | E. López-Melero F. Mota M.I. Ortiz F. Arias de Saavedra I. Porras L. Fernández-Maza J. Praena |
| author_facet | E. López-Melero F. Mota M.I. Ortiz F. Arias de Saavedra I. Porras L. Fernández-Maza J. Praena |
| author_sort | E. López-Melero |
| collection | DOAJ |
| description | The accelerator-based neutron facility IFMIF-DONES is in the final design phase. At present, there is an important effort to optimize other secondary uses compatible with the main goal which is the validation of materials to be used in fusion reactors. One is the production of radioisotopes for nuclear medicine, in particular, Molybdenum-99. The decay of 99Mo produces Technetium-99 metastable. 99mTc is the most used radiopharmaceutical in nuclear medicine, in particular, it is used for SPECT imaging diagnostic. Currently, its production is compromised by the possible closure of some of the few nuclear reactors which produces it, and the search for new alternative ways to obtain it is urgent. This study has been carried out considering three types of molybdenum samples (natural and 95% enriched in 98Mo and 100Mo) and two different positions close to the neutron target. The results of the simulated production are promising and push further studies. |
| first_indexed | 2024-03-08T16:32:39Z |
| format | Article |
| id | doaj.art-cd0ab6ed697140e593139a7219251fe3 |
| institution | Directory Open Access Journal |
| issn | 2352-1791 |
| language | English |
| last_indexed | 2024-04-25T00:05:13Z |
| publishDate | 2024-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Nuclear Materials and Energy |
| spelling | doaj.art-cd0ab6ed697140e593139a7219251fe32024-03-14T06:14:47ZengElsevierNuclear Materials and Energy2352-17912024-03-0138101575Production of 99Mo at IFMIF-DONES reusing the flux of neutronsE. López-Melero0F. Mota1M.I. Ortiz2F. Arias de Saavedra3I. Porras4L. Fernández-Maza5J. Praena6Department of Atomic, Molecular and Nuclear Physics, University of Granada, E-18071, Granada, SpainLaboratorio Nacional de Fusión por Confinamiento Magnético, CIEMAT, E-28040, Madrid, SpainLaboratorio Nacional de Fusión por Confinamiento Magnético, CIEMAT, E-28040, Madrid, SpainDepartment of Atomic, Molecular and Nuclear Physics, University of Granada, E-18071, Granada, SpainDepartment of Atomic, Molecular and Nuclear Physics, University of Granada, E-18071, Granada, SpainPunta de Europa University Hospital, Algeciras, E-11207, Cádiz, SpainDepartment of Atomic, Molecular and Nuclear Physics, University of Granada, E-18071, Granada, Spain; Corresponding author.The accelerator-based neutron facility IFMIF-DONES is in the final design phase. At present, there is an important effort to optimize other secondary uses compatible with the main goal which is the validation of materials to be used in fusion reactors. One is the production of radioisotopes for nuclear medicine, in particular, Molybdenum-99. The decay of 99Mo produces Technetium-99 metastable. 99mTc is the most used radiopharmaceutical in nuclear medicine, in particular, it is used for SPECT imaging diagnostic. Currently, its production is compromised by the possible closure of some of the few nuclear reactors which produces it, and the search for new alternative ways to obtain it is urgent. This study has been carried out considering three types of molybdenum samples (natural and 95% enriched in 98Mo and 100Mo) and two different positions close to the neutron target. The results of the simulated production are promising and push further studies.http://www.sciencedirect.com/science/article/pii/S2352179123002144Accelerator-based neutron source99Mo supply |
| spellingShingle | E. López-Melero F. Mota M.I. Ortiz F. Arias de Saavedra I. Porras L. Fernández-Maza J. Praena Production of 99Mo at IFMIF-DONES reusing the flux of neutrons Nuclear Materials and Energy Accelerator-based neutron source 99Mo supply |
| title | Production of 99Mo at IFMIF-DONES reusing the flux of neutrons |
| title_full | Production of 99Mo at IFMIF-DONES reusing the flux of neutrons |
| title_fullStr | Production of 99Mo at IFMIF-DONES reusing the flux of neutrons |
| title_full_unstemmed | Production of 99Mo at IFMIF-DONES reusing the flux of neutrons |
| title_short | Production of 99Mo at IFMIF-DONES reusing the flux of neutrons |
| title_sort | production of 99mo at ifmif dones reusing the flux of neutrons |
| topic | Accelerator-based neutron source 99Mo supply |
| url | http://www.sciencedirect.com/science/article/pii/S2352179123002144 |
| work_keys_str_mv | AT elopezmelero productionof99moatifmifdonesreusingthefluxofneutrons AT fmota productionof99moatifmifdonesreusingthefluxofneutrons AT miortiz productionof99moatifmifdonesreusingthefluxofneutrons AT fariasdesaavedra productionof99moatifmifdonesreusingthefluxofneutrons AT iporras productionof99moatifmifdonesreusingthefluxofneutrons AT lfernandezmaza productionof99moatifmifdonesreusingthefluxofneutrons AT jpraena productionof99moatifmifdonesreusingthefluxofneutrons |